YLR366W Antibody

Shipped with Ice Packs
In Stock

Description

Research Applications

YLR366W antibody is utilized in diverse experimental contexts:

  • Protein Detection: Confirms YLR366W expression in WB and ELISA, critical for validating genetic modifications (e.g., knockouts or overexpression strains) .

  • Functional Studies: Supports investigations into YLR366W’s role in cellular processes, though specific mechanistic data remain limited in publicly available literature .

  • Comparative Genomics: Facilitates cross-strain analyses, as it is validated for the S288c yeast strain .

Validation and Quality Control

Key validation metrics include:

  • Specificity: Demonstrated through antigen-affinity purification and reactivity assays .

  • Reproducibility: Batch-to-batch consistency is ensured via standardized immunization protocols .

  • Control Recommendations: Use of S. cerevisiae knockout strains is advised to confirm signal specificity, aligning with best practices for antibody validation .

Limitations and Future Directions

  • Research Gaps: Peer-reviewed studies directly employing YLR366W antibody are sparse, highlighting a need for published data on its utility in advanced assays (e.g., ChIP, immunofluorescence) .

  • Cross-Reactivity: No evidence supports reactivity beyond the S288c strain, limiting broader applicability without further validation .

  • Therapeutic Potential: Unlike antibodies targeting human pathogens (e.g., Ebola mAb 3A6 or HIV bNAbs ), YLR366W antibody is confined to basic research contexts.

Comparative Context in Antibody Science

YLR366W antibody exemplifies the importance of well-validated reagents in model organism research. Its development aligns with trends in antibody characterization, as emphasized by initiatives like YCharOS, which advocate for rigorous validation to mitigate reproducibility crises . Unlike clinical-stage antibodies (e.g., bimekizumab for IL-17A/F ), YLR366W antibody remains a tool for foundational discovery.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR366W antibody; L8039.7 antibody; Putative uncharacterized protein YLR366W antibody
Target Names
YLR366W
Uniprot No.

Q&A

What is YLR366W and why would researchers need antibodies against it?

YLR366W is a yeast gene that appears in genomic studies alongside chromatin-associated factors like Arp6 and Swr1, suggesting its potential involvement in chromatin organization or gene regulation . Antibodies against YLR366W enable researchers to study its expression, localization, interactions, and function through techniques including chromatin immunoprecipitation (ChIP), western blotting, and immunofluorescence. These antibodies provide critical tools for understanding YLR366W's role in cellular processes and chromatin dynamics.

What types of antibodies are most suitable for YLR366W research?

Several antibody approaches may be employed for YLR366W research:

  • Polyclonal antibodies: Generated against multiple epitopes of YLR366W, offering broad recognition but potentially higher background

  • Monoclonal antibodies: Provide high specificity for a single epitope, beneficial for distinguishing between closely related proteins

  • Epitope tag systems: Similar to the FLAG-tagged approaches used for Arp6 and Swr1 in chromatin studies , researchers can create tagged YLR366W constructs

  • Modification-specific antibodies: For detecting post-translational modifications if relevant to YLR366W function

Each approach offers distinct advantages depending on experimental requirements and available resources.

How is the specificity of YLR366W antibodies validated?

Rigorous validation protocols for YLR366W antibodies should include:

Validation MethodProcedureExpected Outcome
Western blotCompare wild-type and YLR366W deletion strainsSingle band of correct size in wild-type, absent in deletion
ChIP validationPerform ChIP on known targets vs. non-targetsEnrichment at target sites, minimal signal at control regions
Functionality testingMonitor cell growth/sensitivity (e.g., to hydroxyurea)Preserved function in tagged constructs compared to wild-type
Cross-reactivityTest against related proteinsNo detection of structurally similar proteins

Validation data should be presented with appropriate statistical analysis from at least three independent experiments, similar to approaches used for other yeast proteins in chromatin studies .

What are optimal conditions for YLR366W chromatin immunoprecipitation (ChIP) experiments?

For effective YLR366W ChIP experiments:

  • Crosslinking: 1% formaldehyde for 10-15 minutes at room temperature

  • Chromatin fragmentation: Sonication to achieve 200-500bp fragments, verified by gel electrophoresis

  • Antibody incubation: Typically 2-5μg antibody per sample, incubated overnight at 4°C

  • Washing conditions: Increasing stringency washes to remove non-specific binding

  • Quantification: qPCR analysis expressing results as percentage of input DNA with standard deviation from multiple replicates

When analyzing enrichment patterns, comparison with binding profiles of known chromatin modifiers like Arp6 and Swr1 can provide functional context .

How should YLR366W antibodies be optimized for western blotting in yeast samples?

For optimal western blot detection of YLR366W:

  • Extraction method: Mechanical disruption using glass beads in the presence of protease inhibitors

  • Protein preparation: Include phosphatase inhibitors if post-translational modifications are relevant

  • SDS-PAGE conditions: Select gel percentage based on predicted molecular weight of YLR366W

  • Transfer parameters: Adjust time and voltage based on protein size

  • Blocking: 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Antibody dilution: Test serial dilutions (1:500 to 1:5000) to determine optimal concentration

  • Detection: Enhanced chemiluminescence with exposure time optimization

Include wild-type and knockout controls to confirm specificity, similar to validation approaches used for other chromatin-associated proteins .

Can immunofluorescence microscopy be effectively performed with YLR366W antibodies?

Immunofluorescence for YLR366W in yeast requires special considerations:

  • Cell wall removal: Zymolyase treatment (typically 50-100μg/ml) to generate spheroplasts

  • Fixation method: 3.7% formaldehyde for 30 minutes, which preserves nuclear structure

  • Permeabilization: 0.1% Triton X-100 for optimal antibody access

  • Blocking: 1-5% BSA or normal serum to reduce background

  • Signal detection: Secondary antibodies with bright fluorophores or signal amplification for low-abundance proteins

Nuclear markers should be included to assess co-localization with chromatin, similar to localization studies performed for related chromatin factors in yeast .

How can YLR366W antibodies be applied to study protein-protein interactions within chromatin complexes?

Advanced protein interaction studies using YLR366W antibodies may include:

  • Co-immunoprecipitation (Co-IP): Pull down YLR366W and analyze interacting partners by western blot or mass spectrometry

  • Sequential ChIP (ChIP-reChIP): Perform consecutive immunoprecipitations with YLR366W antibodies and antibodies against potential interacting partners

  • Proximity ligation assay (PLA): Visualize protein interactions in situ with <50nm resolution

  • Crosslinking mass spectrometry: Identify direct binding interfaces between YLR366W and other proteins

Given the appearance of YLR366W in contexts with chromatin factors like Arp6 and Swr1 , these approaches could reveal functional connections within chromatin-modifying complexes.

What approaches resolve contradictory results from different YLR366W antibody sources?

When faced with contradictory results:

  • Epitope mapping: Determine the exact epitopes recognized by different antibodies

  • Sequential protein depletion: Use RNAi or CRISPR to confirm specificity

  • Alternative detection methods: Employ epitope-tagged versions of YLR366W as independent confirmation

  • Batch testing: Compare multiple lots of the same antibody

  • Modification status: Assess whether post-translational modifications affect epitope recognition

Document all variables including fixation conditions, antibody concentrations, and incubation times when comparing results from different antibodies.

How can researchers distinguish between direct and indirect effects in YLR366W ChIP-seq data?

To distinguish direct from indirect binding:

  • Motif analysis: Identify enriched sequence motifs at YLR366W binding sites

  • Binding site overlap: Compare with known chromatin factors like Arp6/Swr1

  • Genetic dependency: Perform ChIP in strains lacking potential recruiting factors

  • High-resolution mapping: Use techniques like ChEC-seq or CUT&RUN for precise localization

  • Functional correlation: Associate binding with gene expression changes using RNA-seq

Analysis ApproachQuestion AddressedOutcome Interpretation
Motif enrichmentIs binding sequence-specific?Enriched motifs suggest direct DNA recognition
Co-occupancy analysisDoes YLR366W bind with other factors?High overlap suggests complex formation or co-recruitment
Mutational analysisWhich domains mediate binding?Binding loss with specific mutations indicates direct interaction
Expression correlationDoes binding correlate with function?Expression changes at bound genes suggest regulatory roles

What controls are essential for reliable YLR366W antibody experiments?

Essential controls include:

  • Genetic controls:

    • Wild-type strain (positive control)

    • YLR366W deletion strain (negative control)

    • Strains with mutations in related pathways

  • Antibody controls:

    • Pre-immune serum or isotype-matched control antibody

    • Competitive blocking with immunizing peptide

    • Secondary-only controls for background assessment

  • Technical controls:

    • Input samples for ChIP experiments (typically 1-5% of starting material)

    • Loading controls for western blots (e.g., actin, tubulin)

    • Unrelated genomic regions for ChIP-qPCR

All experiments should include at least three biological replicates with appropriate statistical analysis, as seen in established chromatin studies .

How should researchers troubleshoot non-specific binding with YLR366W antibodies?

Common troubleshooting approaches include:

  • Blocking optimization:

    • Test different blocking agents (BSA, milk, normal serum)

    • Increase blocking time or concentration

    • Add low concentrations of detergent (0.05-0.1% Tween-20)

  • Antibody conditions:

    • Titrate antibody concentration

    • Reduce incubation time or temperature

    • Pre-adsorb antibody with unrelated proteins

  • Wash optimization:

    • Increase wash stringency (higher salt or detergent)

    • Extend wash duration

    • Add competitor DNA for ChIP applications

  • Sample preparation:

    • Optimize lysis conditions

    • Add protease inhibitors

    • Filter lysates to remove aggregates

When reporting optimized conditions, document all parameters thoroughly to ensure reproducibility .

What quantification methods yield the most reliable data from YLR366W antibody experiments?

Optimal quantification approaches:

  • ChIP experiments:

    • Express as percentage of input DNA

    • Include IgG control for background subtraction

    • Normalize to unaffected control regions

  • Western blot:

    • Use digital imaging with linear dynamic range

    • Normalize to appropriate loading controls

    • Perform densitometry with technical replicates

  • RT-qPCR:

    • Normalize to stable reference genes (e.g., ACT1)

    • Present relative quantification with propagated errors

All quantitative data should be presented as mean ± standard deviation from at least three independent biological replicates, consistent with established practices in chromatin research .

What statistical analyses are appropriate for YLR366W antibody-based experimental data?

Appropriate statistical approaches include:

  • For ChIP experiments:

    • Student's t-test for comparing two conditions at specific loci

    • ANOVA with post-hoc tests for multiple conditions

    • Enrichment analysis relative to genomic features

  • For expression studies:

    • Paired t-tests for before/after comparisons

    • Multiple testing correction for genome-wide analyses

    • Correlation tests for binding vs. expression relationships

  • For localization studies:

    • Colocalization coefficients with known markers

    • Distribution analysis across cellular compartments

Statistical significance should be clearly indicated with exact p-values or adjusted p-values for multiple comparisons, similar to analyses performed in chromatin studies .

How should researchers integrate YLR366W antibody data with other genomic datasets?

For comprehensive data integration:

  • Correlation analyses:

    • YLR366W binding vs. gene expression

    • YLR366W localization vs. chromatin modifications

    • YLR366W recruitment vs. transcription factor binding

  • Functional enrichment:

    • Gene Ontology analysis of YLR366W-bound genes

    • Pathway enrichment of differentially expressed genes in YLR366W mutants

    • Motif enrichment at binding sites

  • Multi-omics integration:

    • Combine ChIP-seq, RNA-seq, and proteomic data

    • Generate integrated network models

    • Correlate with three-dimensional chromatin organization data

Integration approaches should follow established computational workflows used for chromatin modifier studies .

What are the limitations of YLR366W antibody-based research that should be acknowledged?

Important limitations to acknowledge:

  • Antibody-specific limitations:

    • Epitope masking in different chromatin states

    • Cross-reactivity with related proteins

    • Batch-to-batch variability

  • Technique-specific limitations:

    • ChIP resolution limitations (~200-500bp)

    • Fixation artifacts in immunofluorescence

    • Extraction biases in biochemical approaches

  • Biological limitations:

    • Potential functional redundancy with related proteins

    • Context-dependent interactions

    • Cell cycle or condition-specific behaviors

Researchers should clearly state these limitations and validate key findings using complementary approaches, such as combining ChIP with genetic analyses as seen in studies of related chromatin factors .

How can YLR366W antibodies contribute to understanding chromatin organization in yeast?

YLR366W antibodies enable several approaches to chromatin research:

  • Genome-wide binding profiles:

    • ChIP-seq to map YLR366W distribution

    • Correlation with chromatin states and histone modifications

    • Association with specific genomic features (e.g., telomeres, centromeres)

  • Chromatin dynamics:

    • Changes in YLR366W localization during cell cycle

    • Redistribution under environmental stress

    • Recruitment during transcriptional activation/repression

  • Structural studies:

    • Immunoprecipitation for structural analysis of complexes

    • In situ proximity mapping of interaction networks

    • Contribution to higher-order chromatin organization

These approaches build upon established methods for studying chromatin-associated proteins like Arp6 and Swr1 .

What emerging technologies enhance the utility of YLR366W antibodies in research?

Cutting-edge approaches include:

  • High-resolution chromatin mapping:

    • CUT&RUN or CUT&Tag for improved signal-to-noise ratio

    • ChEC-seq for single-nucleotide resolution

    • Micro-C for three-dimensional chromatin contacts

  • Single-cell applications:

    • scCUT&Tag for cell-specific binding profiles

    • Single-cell imaging with antibody-based detection

    • Combining with single-cell transcriptomics

  • Proximity-based methods:

    • BioID or APEX2 fusions for mapping local interactomes

    • CRISPR-based recruitment to test functional hypotheses

    • Live-cell antibody-based tracking

These technologies could significantly enhance our understanding of YLR366W function beyond traditional approaches used in chromatin studies .

How can mass spectrometry complement YLR366W antibody-based findings?

Mass spectrometry provides valuable complementary data:

  • Protein interaction mapping:

    • Identification of proteins co-immunoprecipitated with YLR366W

    • Quantitative assessment of interaction stoichiometry

    • Detection of condition-specific interactions

  • Post-translational modifications:

    • Mapping modification sites on YLR366W

    • Quantifying modification stoichiometry

    • Identifying enzymes responsible for modifications

  • Protein dynamics:

    • Turnover rates using pulse-chase labeling

    • Compartment-specific abundance

    • Complex assembly/disassembly kinetics

Mass spectrometry data should be integrated with antibody-based findings to provide multi-dimensional insights into YLR366W function.

What types of data tables should accompany YLR366W antibody research publications?

Comprehensive publications should include:

Table TypeContentsPurpose
Antibody validationSpecificity metrics, controls tested, optimal concentrationsEstablish reliability of reagents
ChIP enrichmentBinding at different genomic features, statistical significanceDocument genome-wide distribution patterns
Genetic interactionsPhenotypes in combination with related mutationsMap functional relationships
Expression changesDifferentially expressed genes in YLR366W mutantsConnect binding to functional outcomes

Tables should follow the format seen in comprehensive chromatin studies, providing quantitative data with appropriate statistical analysis .

How should researchers present YLR366W localization data from different experimental approaches?

Effective presentation includes:

  • Representative images:

    • Multiple cells showing typical patterns

    • Appropriate controls for background assessment

    • Scale bars and magnification information

  • Quantitative measurements:

    • Signal intensity across cellular compartments

    • Co-localization coefficients with known markers

    • Changes under different conditions

  • Dynamic data:

    • Time-course experiments showing localization changes

    • Cell-cycle dependent patterns

    • Response to environmental stimuli

Visual data should be complemented with quantitative analysis from multiple independent experiments, consistent with established practices in chromatin biology research .

What are the best practices for sharing YLR366W antibody reagents and protocols with the research community?

For maximum reproducibility:

  • Antibody documentation:

    • Complete description of immunogen

    • Validation data including negative controls

    • Storage and handling recommendations

  • Detailed protocols:

    • Step-by-step procedures with timing

    • Buffer compositions with exact concentrations

    • Troubleshooting guidance

  • Resource sharing:

    • Deposit plasmids in public repositories

    • Share specialized reagents through material transfer agreements

    • Provide raw data in public databases

Comprehensive sharing enhances reproducibility across laboratories and accelerates research progress in the field.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.